Home/Pipeline/225Ac‑SSO110

225Ac‑SSO110

Extensive‑stage small cell lung cancer and Merkel cell carcinoma

Phase 1/2Active

Key Facts

Indication
Extensive‑stage small cell lung cancer and Merkel cell carcinoma
Phase
Phase 1/2
Status
Active
Company

About AtomVie Global Radiopharma

A leading radiopharma CDMO delivering end‑to‑end cGMP manufacturing and supply for next‑generation theranostics.

View full company profile

Therapeutic Areas